Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
(2021).
Body composition and arterial stiffness in pediatric patients with chronic kidney disease..
Pediatr Nephrol. 34(7), 1253-1260.
(2019). Prevention of gestational diabetes mellitus in overweight or obese pregnant women: A network meta-analysis..
Diabetes Res Clin Pract. 158, 107924.
(2019). Edmonton obesity staging system among pediatric patients: a validation and obesogenic risk factor analysis..
J Endocrinol Invest. 41(8), 947-957.
(2018). Growth, the Mediterranean diet and the buying power of adolescents in Greece..
J Pediatr Endocrinol Metab. 31(7), 773-780.
(2018). Association analysis of FTO gene polymorphisms with obesity in Greek adults..
Gene. 613, 10-13.
(2017). The role of acetic acid on glucose uptake and blood flow rates in the skeletal muscle in humans with impaired glucose tolerance..
Eur J Clin Nutr. 69(6), 734-9.
(2015). The role of orlistat combined with lifestyle changes in the management of overweight and obese patients with polycystic ovary syndrome..
Clin Endocrinol (Oxf). 80(3), 432-8.
(2014). A systematic review and meta-analysis of weight status among adolescents in Cyprus: scrutinizing the data for the years 2000-2010..
Hormones (Athens). 13(4), 543-51.
(2014). Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome..
Hum Reprod. 28(3), 785-93.
(2013). Diet, physical exercise and Orlistat administration increase serum anti-Müllerian hormone (AMH) levels in women with polycystic ovary syndrome (PCOS)..
Gynecol Endocrinol. 29(3), 242-5.
(2013). Disparate effects of pharmacotherapy on plasma plasminogen activator inhibitor-1 levels in women with the polycystic ovary syndrome..
Hormones (Athens). 12(4), 559-66.
(2013). The guidelines issued by the European Society for Human Reproduction and Embryology and the American Society for Reproductive Medicine regarding the induction of ovulation with metformin in patients with the polycystic ovary syndrome potentially require r.
Hormones (Athens). 12(2), 192-200.
(2013). Platelet-derived microparticles in overweight/obese women with the polycystic ovary syndrome..
Gynecol Endocrinol. 29(3), 250-3.
(2013). Ten-year obesity and overweight prevalence in Greek children: a systematic review and meta-analysis of 2001-2010 data..
Hormones (Athens). 12(4), 537-49.
(2013). Underweight, overweight and obesity in paediatric dialysis and renal transplant patients..
Nephrol Dial Transplant. 28 Suppl 4, iv195-iv204.
(2013). Age, weight and obesity..
Maturitas. 71(2), 115-9.
(2012). Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study..
Hum Reprod. 27(2), 541-9.
(2012). Plasma plasminogen activator inhibitor-1 levels in the different phenotypes of the polycystic ovary syndrome..
Endocr J. 59(1), 21-9.
(2012). Weight loss significantly reduces serum lipocalin-2 levels in overweight and obese women with polycystic ovary syndrome..
Gynecol Endocrinol. 28(1), 20-4.
(2012). The effect of weight loss and treatment with metformin on serum vaspin levels in women with polycystic ovary syndrome..
Endocr J. 58(4), 237-46.
(2011). Phenotypic expression, body mass index and insulin resistance in relation to LH levels in women with polycystic ovary syndrome..
Eur J Obstet Gynecol Reprod Biol. 156(2), 181-5.
(2011). Eating habits, health attitudes and obesity indices among medical students in northern Greece..
Appetite. 55(3), 722-5.
(2010). The effects of obesity and polycystic ovary syndrome on serum lipocalin-2 levels: a cross-sectional study..
Reprod Biol Endocrinol. 8, 151.
(2010). Nutrient intake and anthropometry in children and adolescents with Down syndrome--a preliminary study..
Dev Neurorehabil. 11(4), 260-7.
(2008).